Live feed
Filing
SC 13G
SC 13G0001193125-24-036609·Bain Capital Life Sciences Opportunities III, LP
Schedule 13G ownership disclosure
Kyverna Therapeutics, Inc.
Security class unavailable · CUSIP: 501976104
Event date: 2024-02-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-036609
- Form type
- SC 13G
- Filer
- Bain Capital Life Sciences Opportunities III, LP
- CIK
- CIK 1950105
- Filed
- Feb 14, 2024
- Reporting period
- Feb 07, 2024
- Description
- Schedule 13G beneficial ownership